Related Experiment Video
Updated: Jun 18, 2026

05:52
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
Sentinel lymph node biopsy in Japan.
Hisashi Uhara1, Minoru Takata, Toshiaki Saida
1Department of Dermatology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan. uhara@shinshu-u.ac.jp
International Journal of Clinical Oncology
|December 8, 2009
Summary
Sentinel lymph node biopsy (SLNB) is a standard melanoma staging procedure in Japan, with high detection rates and metastasis rates correlating with tumor stage and ulceration.
Area of Science:
- Oncology
- Surgical Pathology
- Dermatology
Background:
- Intraoperative lymphatic mapping and selected lymphadenectomy (SLNB) are validated melanoma staging procedures in Japan, mirroring Western practices.
- Approximately 90% of Japanese university and cancer hospitals routinely perform SLNB, with about half of all melanoma patients undergoing the procedure.
Purpose of the Study:
- To discuss data from Japanese patients regarding the current status of SLNB for melanoma staging.
- To present the metastasis rates in sentinel lymph nodes (SLNs) based on tumor stage and primary tumor characteristics.
Main Methods:
- SLNB performed using variations of the Morton and Cochran standard procedure.
- Commonly used tracers include Tc(99m)-tin colloid or Tc(99m)-phytate for scintigraphy and patent blue violet or indigo carmine as blue dye.
- Indocyanine green is used in some institutions for fluorescent visualization under infrared cameras; detection rates exceed 95% with combined methods.
Main Results:
- Melanoma metastasis rates in SLNs varied significantly by pathological tumor stage (pTis: 0%, pT1: 10.7%, pT2: 21.0%, pT3: 34.0%, pT4: 62.4%).
- A significant correlation was observed between SLN metastasis rates and the presence of ulceration in the primary tumor.
Conclusions:
- SLNB is a widely adopted and effective method for melanoma staging in Japan.
- Tumor stage and ulceration are critical factors influencing metastasis risk in Japanese melanoma patients undergoing SLNB.
